OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,884 | -47.2% | 174,167 | -13.3% | 0.01% | -58.3% |
| Q2 2023 | $1,036,350 | +287775.0% | 200,843 | +193.7% | 0.01% | +100.0% |
| Q1 2023 | $360 | +29.0% | 68,384 | -31.2% | 0.01% | 0.0% |
| Q4 2022 | $279 | -99.9% | 99,338 | +60.8% | 0.01% | 0.0% |
| Q3 2022 | $256,000 | +24.9% | 61,775 | +21.0% | 0.01% | +20.0% |
| Q2 2022 | $205,000 | -28.3% | 51,039 | +24.5% | 0.01% | 0.0% |
| Q4 2021 | $286,000 | -69.8% | 40,987 | -56.7% | 0.01% | -66.7% |
| Q3 2021 | $947,000 | +695.8% | 94,712 | +645.8% | 0.02% | +400.0% |
| Q4 2015 | $119,000 | -67.9% | 12,700 | -28.1% | 0.00% | -72.7% |
| Q2 2015 | $371,000 | – | 17,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |